We haven't been able to take payment
You must update your payment details via My Account or by clicking update payment details to keep your subscription.
Act now to keep your subscription
We've tried to contact you several times as we haven't been able to take payment. You must update your payment details via My Account or by clicking update payment details to keep your subscription.
Your subscription is due to terminate
We've tried to contact you several times as we haven't been able to take payment. You must update your payment details via My Account, otherwise your subscription will terminate.

Stop Press

Video by phone

EMI Music is teaming up with T-Mobile to test an advertising-supported video service for mobile phone users. EMI Music, part of EMI Group, said that it would supply music videos from artists including Lily Allen and Gorillaz to be available by mobile phone. However, the T-Mobile trial will also include news, sports and other video programming.

US Army contract

Boeing said that it is was one of six companies selected to compete for a $5 billion (£2.7 billion) satellite communications system programme for the US Army. The five-year, indefinite delivery, indefinite quantity contract is for six satellite terminal types, operating on a variety of military and commercial satellite bands, the company said in a statement.

Scottish Re offers

Advertisement

Scottish Re Group, the life insurer that said in July that it would consider a possible sale, has said that it has received a number of potential bid proposals and is reviewing them. Selected parties will be invited to a second round, the Bermuda-based company said. A transaction could be announced as early as next month.

Little Tikes sale

Newell Rubbermaid said that it planned to sell its Little Tikes toy and play equipment business to MGA Entertainment, the privately held maker of Bratz dolls, as it focuses on higher-growth businesses. The parties did not disclose financial terms. Little Tikes contributed about $250 million to Newell’s overall revenue last year.

Drug demands

Genentech said that regulators wanted more information about the safety and efficacy of Avastin, its cancer drug, before approving it as an initial treatment for metastatic breast cancer. The San Francisco-based biotechnology company said that the US Food and Drug Administration had requested an independent review of patient scans.